Home
>
National Drug Code (NDC)
>
Glyburide (micronized) and Metformin Hydrochloride
Glyburide (micronized) and Metformin Hydrochloride - 14550-517-02 - (Glyburide (micronized) and Metformin Hydrochloride)
Drug Information of Glyburide (micronized) and Metformin Hydrochloride
| Product NDC: | 14550-517 |
| Proprietary Name: | Glyburide (micronized) and Metformin Hydrochloride |
| Non Proprietary Name: | Glyburide (micronized) and Metformin Hydrochloride |
| Active Ingredient(s): | 1.25; 250 mg/1; mg/1 & nbsp; Glyburide (micronized) and Metformin Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glyburide (micronized) and Metformin Hydrochloride
| Product NDC: | 14550-517 |
| Labeler Name: | Actavis Pharma Manufacturing Pvt. Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076716 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100503 |
Package Information of Glyburide (micronized) and Metformin Hydrochloride
| Package NDC: | 14550-517-02 |
| Package Description: | 100 TABLET in 1 BOTTLE (14550-517-02) |
NDC Information of Glyburide (micronized) and Metformin Hydrochloride
| NDC Code | 14550-517-02 |
| Proprietary Name | Glyburide (micronized) and Metformin Hydrochloride |
| Package Description | 100 TABLET in 1 BOTTLE (14550-517-02) |
| Product NDC | 14550-517 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glyburide (micronized) and Metformin Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100503 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Pharma Manufacturing Pvt. Ltd. |
| Substance Name | GLYBURIDE; METFORMIN HYDROCHLORIDE |
| Strength Number | 1.25; 250 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
